BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23812298)

  • 1. Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.
    Gomaraschi M; Ossoli A; Favari E; Adorni MP; Sinagra G; Cattin L; Veglia F; Bernini F; Franceschini G; Calabresi L
    Cardiovasc Res; 2013 Oct; 100(1):36-43. PubMed ID: 23812298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
    Ossoli A; Simonelli S; Varrenti M; Morici N; Oliva F; Stucchi M; Gomaraschi M; Strazzella A; Arnaboldi L; Thomas MJ; Sorci-Thomas MG; Corsini A; Veglia F; Franceschini G; Karathanasis SK; Calabresi L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):915-924. PubMed ID: 30894011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.
    Besler C; Heinrich K; Rohrer L; Doerries C; Riwanto M; Shih DM; Chroni A; Yonekawa K; Stein S; Schaefer N; Mueller M; Akhmedov A; Daniil G; Manes C; Templin C; Wyss C; Maier W; Tanner FC; Matter CM; Corti R; Furlong C; Lusis AJ; von Eckardstein A; Fogelman AM; Lüscher TF; Landmesser U
    J Clin Invest; 2011 Jul; 121(7):2693-708. PubMed ID: 21701070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability.
    Carvalho LS; Panzoldo N; Santos SN; Modolo R; Almeida B; Quinaglia E Silva JC; Nadruz W; de Faria EC; Sposito AC;
    Atherosclerosis; 2014 Dec; 237(2):840-6. PubMed ID: 25463131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment.
    Denimal D; Monier S; Brindisi MC; Petit JM; Bouillet B; Nguyen A; Demizieux L; Simoneau I; Pais de Barros JP; Vergès B; Duvillard L
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):804-811. PubMed ID: 28360087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-carotene reverses the IL-1β-mediated reduction in paraoxonase-1 expression via induction of the CaMKKII pathway in human endothelial cells.
    Yamagata K; Tanaka N; Matsufuji H; Chino M
    Microvasc Res; 2012 Nov; 84(3):297-305. PubMed ID: 22750393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Walk-run training improves the anti-inflammation properties of high-density lipoprotein in patients with metabolic syndrome.
    Sang H; Yao S; Zhang L; Li X; Yang N; Zhao J; Zhao L; Si Y; Zhang Y; Lv X; Xue Y; Qin S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):870-9. PubMed ID: 25514103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
    Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
    J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated CETP activity during acute phase of myocardial infarction is independently associated with endothelial dysfunction and adverse clinical outcome.
    Carvalho LS; Virginio VW; Panzoldo NB; Figueiredo VN; Santos SN; Modolo RG; Andrade JM; Quinaglia E Silva JC; Nadruz-Junior W; de Faria EC; Sposito AC;
    Atherosclerosis; 2014 Dec; 237(2):777-83. PubMed ID: 25463120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality.
    Shih CM; Lin FY; Yeh JS; Lin YW; Loh SH; Tsao NW; Nakagami H; Morishita R; Sawamura T; Li CY; Lin CY; Huang CY
    Transl Res; 2019 Mar; 205():17-32. PubMed ID: 30720435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction.
    Gomaraschi M; Sinagra G; Serdoz LV; Pitzorno C; Fonda M; Cattin L; Calabresi L; Franceschini G
    Atherosclerosis; 2009 Jan; 202(1):304-11. PubMed ID: 18486943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium.
    Andrews KL; Moore XL; Chin-Dusting JP
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):736-42. PubMed ID: 20374256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
    Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
    Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoproteins (HDL) composition and function in preeclampsia.
    Einbinder Y; Biron-Shental T; Agassi-Zaitler M; Tzadikevitch-Geffen K; Vaya J; Khatib S; Ohana M; Benchetrit S; Zitman-Gal T
    Arch Gynecol Obstet; 2018 Aug; 298(2):405-413. PubMed ID: 29938347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.